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silencing by a mechanism that involves targeted degra-RNAi on the Apoptosis TRAIL:
dation of the cognate cellular mRNA (reviewed in Han-The Mammalian Cell non, 2002). Although the RNAi phenomenon rapidly
came into common use for targeted gene “knockdown”Genetic Screen Comes of Age
in C. elegans and other organisms (reviewed in Hannon,
2002), it was initially thought that the approach would
not be useful in mammals, because dsRNA triggers
translational blockade and nonspecific mRNA degrada-
tion as part of the interferon response in mammalianPresented in a paper in the September issue of Molec-
cells (Stark et al., 1998). That view changed in 2001 whenular Cell, Aza-Blanc et al. used an RNA interference-
it was shown that genes could be targeted by RNAibased genetic screen to identify genes that modulate
while evading the interferon response by using shortsensitivity to the apoptosis-inducing ligand TRAIL. The
dsRNAs of 21 nucleotide length, known as siRNAs (shortage of mammalian cell genetic screens has begun.
interfering RNAs; Elbashir et al., 2001). This suggested
the possibility of screening large numbers of genes in
The forward genetic screen is a powerful approach for cultured mammalian cells by examining the cells for
identifying genes involved in biological processes. Al- phenotypes of interest following RNAi. In fact, such
though the strategy has enjoyed extraordinary success large-scale screens have been successfully carried out
in certain model systems, genetic screens are laborious in C. elegans (the earliest screens included Piano et al.,
endeavors in more complex organisms such as mam- 2000; Fraser et al., 2000; Go¨nczy et al., 2000) as well as
mals. And for investigators studying mammalian cell in a cultured cell model using Drosophila cells (Lum et
culture systems, loss-of-function genetic screens have al., 2003). The study by Aza-Blanc et al. now demon-
been largely out of reach. But, as a report in the Septem- strates the usefulness of extending this approach to
ber issue of Molecular Cell shows (Aza-Blanc et al., mammalian cells, and provides tangible results per-
2003), that was before RNA interference (RNAi). taining to an important cellular signaling pathway.
RNAi refers to the startling observation that introduc- The authors studied the molecular pathway of apopto-
tion of double-stranded RNA (dsRNA) corresponding to sis initiated by TRAIL, a secreted protein ligand that
induces apoptosis by binding its cognate cell surfacea gene of interest can lead to sequence-specific gene
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receptor (reviewed by Ashkenazi and Dixit, 1999). TRAIL of the screen. In addition, there can be considerable
experimental variability in the degree of knockdown us-is of great medical interest because it can induce apo-
ptosis selectively in tumor cells, leaving nontransformed ing RNAi. This experimental noise can make more subtle
effects difficult to discern, and can make detailed andcells unharmed (reviewed by Ashkenazi and Dixit, 1999).
The basis for this tumor cell selectivity remains an active precise genetic analysis difficult. Thus, RNAi may not
be a satisfactory method of gene knockdown when morearea of investigation, and may have important implica-
tions for cancer therapy. in-depth molecular studies are required.
Despite these limitations, it is clear that RNAi-basedTo better understand the molecular details of TRAIL
signaling, Aza-Blanc et al. carried out an RNAi-based screens can greatly accelerate the pace at which new
genes involved in biological processes are identified.screen to identify modulators of TRAIL-induced apopto-
sis in HeLa cells. They used siRNAs to individually target The role of such screens in experimental biology may
be to identify genes that will serve as starting points for510 human genes (corresponding to 380 predicted ki-
nases and 130 other predicted proteins). Sensitivity to deeper explorations of molecular mechanisms.
From a genomic perspective, RNAi-based loss-of-TRAIL-induced apoptosis was examined following gene
knockdown by siRNAs, using an assay that could detect function screens are a powerful adjunct to existing func-
tional genomic approaches in mammalian cells. As hasboth sensitization and resistance to TRAIL-induced apo-
ptosis. A number of apparent modulators, both posi- been seen with C. elegans (Walhout et al., 2002), integra-
tion of data emerging from large-scale RNAi screenstively and negatively acting, were identified. Reassur-
ingly, some of these genes encode known mediators with results from other approaches such as expression
profiling and protein interaction mapping will be an im-of TRAIL-induced apoptosis, including the receptor for
TRAIL (known as DR4) and CASP8, which is a known portant direction for future research.
We can soon expect to see a flurry of papers reportingapoptosis effector. Another group includes genes such
as MYC and JNK3, which are known modulators of apo- RNAi-based genetic screens in mammalian cells. Given
that the number of phenotypes and assays that can beptosis in other contexts, but which had not previously
been implicated in TRAIL-induced apoptosis. screened for is almost limitless, we will shortly have in
hand many lists of genes linked to various processes.But perhaps the most interesting category is that of
genes that had no known role in apoptosis in any system, As with other functional genomics efforts, understand-
ing how they all work together as a biological systembut which were found in the RNAi screen to modulate
TRAIL-induced apoptosis. One of the genes in this class will continue to be the next challenge.
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tein without a well-understood molecular function, it
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In addition to identifying new molecules that regulate
Fraser, A.G., Kamath, R.S., Zipperlen, P., Martinez-Campos, M.,
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pathways. As RNAi screens gain popularity and the Hannon, G.J. (2002). Nature 418, 244–251.
amount of collective data accumulates, we can expect Lum, L., Yao, S., Mozer, B., Rovescalli, A., Von Kessler, D., Nirenberg,
to see many more examples of this in the future. M., and Beachy, P.A. (2003). Science 299, 2039–2045.
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